Antisense and RNAi Therapeutics Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecasts 2016–2024

Report Code: ZMR-2924 | Report Format : | Status : Upcoming |

Abstract

Global Antisense and RNAi Therapeutics Market: Overview

The global antisense and RNAi therapeutics market have garnered considerable attention in the recent years owing to its perspective to treat a range of chronic diseases such as diabetes, cancer, tuberculosis, AIDS, as well as certain cardiovascular problems. In spite of being in the clinical research division, the RNA based therapeutics are likely to be explored as a most potential treatment choice for the syndromes which are very difficult to treat.

Global Antisense and RNAi Therapeutics Market: Growth Factors

Gene silencing prospective of RNA based therapeutics is the most important aspect for the development of this global market. The other growth factors comprise target selectivity and specificity of RNAi therapeutics, more powerful product focus vs. platform technologies as well as virtual drug expansion models that enable several companies to decrease the research expenditure. On the other hand, significant problems in drug delivery, the high price of research, as well as high failure rates are few of the most important hurdles for several companies working in this particular field. Despite the limitations, antisense and RNAi therapeutics market have chances to develop owing to growing interest exhibited by the pharmaceutical sectors for the commercialization of these therapies.

Global Antisense and RNAi Therapeutics Market: Segmentation

The global antisense and RNAi therapeutics market are fragmented into technology, application, route of administration. In terms of technology, the global antisense and RNAi therapeutics market is divided into RNA interference and antisense RNA. The division RNA interference is further sub-divided into miRNA and siRNA. In terms of application, the global antisense and RNAi therapeutics market are categorized into cardiovascular, oncology, renal diseases, respiratory disorder, genetic disorders, a neurodegenerative disorder, infectious diseases, and others. In terms of route of administration, the global antisense and RNAi therapeutics market is segmented into intravenous injections, pulmonary delivery, intraperitoneal injections, intradermal Injections, topical delivery, and other delivery methods.

Global Antisense and RNAi Therapeutics Market: Regional Analysis

North America witnessed to be the most lucrative market in the past and has therefore contributed a substantial share to the overall sector. Support to increase the number of clinical trials and favorable government regulation therein aids the method of initiation for expanding antisense therapeutics. In North America, clinical laboratories are likely to contribute significant revenue generation via platform and product licensing. The impending commercialization of several candidates under R&D will help to boost the global antisense and RNAi therapeutics market to pick rapid pace in North America in the coming years.

On the other hand, post commercialization of these therapies, prospects, and opportunities in the Asia Pacific have expected to be more profitable, exhibiting a maximum development rate. The increasing government expenditure toward R&D, besides other different forms of siRNA delivery methods, is a strong aspect propelling the growth of the global antisense and RNAi therapeutics market in Asia Pacific region.

Global Antisense and RNAi Therapeutics Market: Competitive Players

Some of the most important market players in the global antisense and RNAi therapeutics market are Benitec Biopharma, Sanofi-Genzyme, GSK, Marina Biosciences, and Alnylam Pharmaceuticals, among others.

Global Antisense and RNAi Therapeutics Market: Regional Segment Analysis

  • North America
    • The U.S.
  • Europe
    • The UK
    • France
    • Germany
  • The Asia Pacific
    • China
    • Japan
    • India
  • Latin America
    • Brazil
  • The Middle East and Africa

What Reports Provides

  • Full in-depth analysis of the parent market
  • Important changes in market dynamics
  • Segmentation details of the market
  • Former, on-going, and projected market analysis in terms of volume and value
  • Assessment of niche industry developments
  • Market share analysis
  • Key strategies of major players
  • Emerging segments and regional markets
  • Testimonials to companies in order to fortify their foothold in the market.

Related Reports

Rheumatoid Arthritis Drugs Market by Drug Type (NSAID’s, Analgesics, DMARD’s, Glucocorticoids, Biologics, and Others) and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Drug Stores, and Online Sales): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025

Apr-2019 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3999 | Report Format:

The report covers a forecast and an analysis of the rheumatoid arthritis drugs market on a global and regional level. The study provides historical data from 2016 to 2018 along with a forecast from 2019 to 2025 based on revenue (USD Billion). The study includes drivers and restraints of the rheuma...Read More

Pharmaceutical Vials Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026

Price : $ 3999.00 | Report Code: ZMR-3985 | Report Format:

Global Pharmaceutical Vials Market: Overview Pharmaceutical vials are a type of small containers that are used for the purpose of storing liquid medications. They are made up of plastic or glass and are mainly used for unit dose packaging of medications. Pharmaceutical vials also help patients i...Read More

Immuno Oncology Assays Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026

Price : $ 3999.00 | Report Code: ZMR-3963 | Report Format:

Global Immuno Oncology Assays Market: Overview Immuno Oncology Assays are used when testing immunotherapies as it is often critical to assess thefunctional cytotoxicity and infiltration capacity. In addition, Immunomodulators effects of these new drugs in combination with already approved ones n...Read More

Drug Integrated Polymer Fibers Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2018–2026

Price : $ 3999.00 | Report Code: ZMR-3933 | Report Format:

Global Drug Integrated Polymer Fibers Market: Overview Drug integrated polymers fibers are generally made from biodegradable and biocompatible materials such as poly lactic acid and its derivatives such as PLLA, polydioxanone, polycaprolactone, polyglycolic acid, poly(lactic-co-glycolic acid), a...Read More

Gynecological Drugs Market by Therapeutics (Hormonal Therapy and Non-Hormonal Therapy), by Indication (Gynecology Cancers, Endometriosis, Female Infertility, Menopausal Disorder, Gynecology Infections, Polycystic Ovary Syndrome, Contraception (Birth Control), and Others), and by Distribution Channel (Hospital Pharmacies, Retail Pharmacies, and Online Pharmacies): Global Industry Perspective, Comprehensive Analysis, and Forecast, 2018–2025

Mar-2019 | Price : $ 4899.00 | Pages: 110 | Report Code: ZMR-3926 | Report Format:

The report covers a forecast and an analysis of the gynecological drugs market on a global and regional level. The study provides historical data for 2016, 2017, and 2018 along with a forecast from 2019 to 2025 based on revenue (USD Million). The study includes drivers and restraints of the gyneco...Read More

Download Brochure
Why Choose Us ?

24/5 Research support

Resolved your research queries from industry expert. Request for a free research sample before report purchase.

Custom research service

Ask the Analyst to customize an exclusive study to serve your research needs.

Quality & Accuracy

Zion Market Research reports offers best quality reports based on various authentic and accurate data findings.

Customer Satisfaction

We ensure that our client's all research needs are met with customized, in-depth analysis solutions.

Information security

We never share your personal and confidential information. Your personal information is safe and secure with us.